共 50 条
- [1] In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugateCANCER RESEARCH, 2015, 75Meyer, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAJenkins, David论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Gaithersburg, MD USA Novartis Inst Biomed Res, Cambridge, MA USABatt, David论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAMosher, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAIsaacs, Randi论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, E Hanover, NJ USA Novartis Inst Biomed Res, Cambridge, MA USAHu, Tiancen论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USACapka, Vladimir论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAZhang, Xiamei论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAChen, Dongshu论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USATang, Lujia论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USADaley, Mike论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USANowakowski, Patrycja论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAShim, Yeonju论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USAJiang, Wei论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Rahway, NJ USA Novartis Inst Biomed Res, Cambridge, MA USAEttenberg, Seth论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USALees, Emma论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst Biomed Res, Cambridge, MA USA Novartis Inst Biomed Res, Cambridge, MA USA
- [2] Potent tumoricidal activity of a FGFR4 CART in rhabdomyosarcoma.CANCER RESEARCH, 2021, 81 (13)Cheuk, Adam论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USATian, Meijie论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAKumar, Jeetendra论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAAzorsa, Peter论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAShivaprasad, Nityashree论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USASchneider, Dina论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol, Gaithersburg, MD USA NCI, NIH, Bethesda, MD 20892 USAGryder, Berkley论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAWei, Jun论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USASong, Young论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAWen, Xinyu论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USASindiri, Sivasish论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAChung, Joon-Yong论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USAZhu, Zhongyu论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol, Gaithersburg, MD USA NCI, NIH, Bethesda, MD 20892 USADimitrov, Dimiter论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USA NCI, NIH, Bethesda, MD 20892 USAHewitt, Stephen论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USADropulic, Boro论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol, Gaithersburg, MD USA NCI, NIH, Bethesda, MD 20892 USAOrentas, Rimas论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA NCI, NIH, Bethesda, MD 20892 USAKhan, Javed论文数: 0 引用数: 0 h-index: 0机构: NCI, NIH, Bethesda, MD 20892 USA NCI, NIH, Bethesda, MD 20892 USA
- [3] Antibody-based targeting of the cell surface receptor tyrosine kinase FGFR4 in rhabdomyosarcoma and other cancersCANCER RESEARCH, 2017, 77Skarzynski, Martin论文数: 0 引用数: 0 h-index: 0Shivaprasad, Nitya论文数: 0 引用数: 0 h-index: 0Subramanian, Baskar论文数: 0 引用数: 0 h-index: 0Azorsa, David论文数: 0 引用数: 0 h-index: 0Zhu, Zhongyu论文数: 0 引用数: 0 h-index: 0Dimitrov, Dimiter论文数: 0 引用数: 0 h-index: 0Khan, Javed论文数: 0 引用数: 0 h-index: 0
- [4] Anti-FGFR4 antibody drug conjugate for immune therapy of rhabdomyosarcoma and hepatocellular carcinomaCANCER RESEARCH, 2018, 78 (13)Cheuk, Adam论文数: 0 引用数: 0 h-index: 0机构: Leidos Biomed Res Inc, Bethesda, MD USA Leidos Biomed Res Inc, Bethesda, MD USAShivaprasad, Nitya论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Leidos Biomed Res Inc, Bethesda, MD USASkarzynski, Martin论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Leidos Biomed Res Inc, Bethesda, MD USABaskar, Sivasubramanian论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Leidos Biomed Res Inc, Bethesda, MD USAAzorsa, Peter论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Leidos Biomed Res Inc, Bethesda, MD USAKhan, Javed论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA Leidos Biomed Res Inc, Bethesda, MD USA
- [5] Development of FGFR4-targeted chimeric antigen receptors (CARs) for the treatment of rhabdomyosarcoma.CANCER RESEARCH, 2021, 81 (13)Sullivan, Peter论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Seattle, WA USA Seattle Childrens Res Inst, Seattle, WA USAKumar, Rajesh论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Seattle, WA USA Seattle Childrens Res Inst, Seattle, WA USALi, Wei论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Sch Med, Pittsburgh, PA USA Seattle Childrens Res Inst, Seattle, WA USAWang, Lingyang论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Seattle, WA USA Seattle Childrens Res Inst, Seattle, WA USAZhang, Yue论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Seattle, WA USA Seattle Childrens Res Inst, Seattle, WA USACheuk, Adam论文数: 0 引用数: 0 h-index: 0机构: NCI, CCR, NIH, Bethesda, MD 20892 USA Seattle Childrens Res Inst, Seattle, WA USAShivaprasad, Nityashree论文数: 0 引用数: 0 h-index: 0机构: NCI, CCR, NIH, Bethesda, MD 20892 USA Seattle Childrens Res Inst, Seattle, WA USAKhan, Javed论文数: 0 引用数: 0 h-index: 0机构: NCI, CCR, NIH, Bethesda, MD 20892 USA Seattle Childrens Res Inst, Seattle, WA USADimitrov, Dimiter S.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Sch Med, Pittsburgh, PA USA Seattle Childrens Res Inst, Seattle, WA USAOrentas, Rimas J.论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Seattle, WA USA Seattle Childrens Res Inst, Seattle, WA USA
- [6] Potent antitumor activity of a FGFR4 CAR-T in rhabdomyosarcoma.CANCER RESEARCH, 2022, 82 (12)Cheuk, Adam Tai Chi论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USATian, Meijie论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAShivaprasad, Nityashree论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAHighfill, Steven论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAMilewski, David论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USABrown, G. Tom论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAAzorsa, Peter论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USASchneider, Dina论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Incorp, Gaithersburg, MD USA NCI, Bethesda, MD 20892 USAGryder, Berkley论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAWei, Jun S.论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USASong, Young Kwok论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAChou, Hsien-Chao论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAWu, Jerry论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USAChung, Joon-Yong论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USABelyea, Brian论文数: 0 引用数: 0 h-index: 0机构: Univ Virginia, Child Hlth Res Ctr, Charlottesville, VA USA NCI, Bethesda, MD 20892 USA论文数: 引用数: h-index:机构:Hewitt, Stephen M.论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USADropulic, Boro论文数: 0 引用数: 0 h-index: 0机构: Caring Cross, Gaithersburg, MD USA NCI, Bethesda, MD 20892 USAOrentas, Rimas论文数: 0 引用数: 0 h-index: 0机构: Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA NCI, Bethesda, MD 20892 USAKhan, Javed论文数: 0 引用数: 0 h-index: 0机构: NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA
- [7] Identification of resistance mechanisms to FGFR4 targeted therapy in hepatocellular carcinomaMOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)Hatlen, Megan A.论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USASchmidt-Kittler, Oleg论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USASherwin, Cori-Ann论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USARozsahegyi, Emily论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USARubin, Nooreen论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USASheets, Michael论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAKim, Joseph L.论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAMiduturu, Chandra论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USABifulco, Neil论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USABrooijmans, Natasja论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAShi, Hongliang论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAGuzi, Timothy论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USABoral, Andy论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USALengauer, Christoph论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USADorsch, Marion论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAKim, Richard D.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Blueprint Medicines, Cambridge, MA USAKang, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea Blueprint Medicines, Cambridge, MA USAWolf, Beni B.论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USAHoeflich, Klaus P.论文数: 0 引用数: 0 h-index: 0机构: Blueprint Medicines, Cambridge, MA USA Blueprint Medicines, Cambridge, MA USA
- [8] Combination FGFR4 and ER-targeted therapy for invasive lobular carcinomaCANCER RESEARCH, 2018, 78 (04)Levine, Kevin M.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAChen, Jian论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USASikora, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USATasdemir, Nilgun论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAPriedigkeit, Nolan论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USATseng, George C.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAPuhalla, Shannon L.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAJankowitz, Rachel C.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USADabbs, David J.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAMcAuliffe, Priscilla F.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USALee, Adrian V.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USAOesterreich, Steffi论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Pittsburgh, PA USA
- [9] Combination FGFR4 and ER-targeted therapy for invasive lobular carcinomaCANCER RESEARCH, 2017, 77Levine, Kevin论文数: 0 引用数: 0 h-index: 0Chen, Jian论文数: 0 引用数: 0 h-index: 0Sikora, Matthew论文数: 0 引用数: 0 h-index: 0Tasdemir, Nilgun论文数: 0 引用数: 0 h-index: 0Tseng, George论文数: 0 引用数: 0 h-index: 0Puhalla, Shannon论文数: 0 引用数: 0 h-index: 0Jankowitz, Rachel论文数: 0 引用数: 0 h-index: 0Dabbs, David论文数: 0 引用数: 0 h-index: 0McAuliffe, Priscilla论文数: 0 引用数: 0 h-index: 0Lee, Adrian论文数: 0 引用数: 0 h-index: 0Oesterreich, Steffi论文数: 0 引用数: 0 h-index: 0
- [10] FGFR4 specific chimeric antigen receptor (CAR) T cell therapy against rhabdomyosarcomaJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Shivaprasad, Nityashree论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USAYohe, Marielle论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USAXiong, Ying论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Inc, Gaithersburg, MD USA NIH, Bldg 10, Bethesda, MD 20892 USAWu, Darong论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Inc, Gaithersburg, MD USA NIH, Bldg 10, Bethesda, MD 20892 USAAzorsa, Peter论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USACheuck, Adam论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USAChung, Joon-Yong论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USAZhu, Zhongyu论文数: 0 引用数: 0 h-index: 0机构: NIH, Frederick, MD USA NIH, Bldg 10, Bethesda, MD 20892 USADimitrov, Dimiter论文数: 0 引用数: 0 h-index: 0机构: NIH, Frederick, MD USA NIH, Bldg 10, Bethesda, MD 20892 USAHewitt, Stephen论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USADropulic, Boro论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Inc, Gaithersburg, MD USA NIH, Bldg 10, Bethesda, MD 20892 USASchneider, Dina论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Inc, Gaithersburg, MD USA NIH, Bldg 10, Bethesda, MD 20892 USAOrentas, Rimas论文数: 0 引用数: 0 h-index: 0机构: Lentigen Technol Inc, Gaithersburg, MD USA NIH, Bldg 10, Bethesda, MD 20892 USAKhan, Javed论文数: 0 引用数: 0 h-index: 0机构: NIH, Bldg 10, Bethesda, MD 20892 USA NIH, Bldg 10, Bethesda, MD 20892 USA